{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T06:19:47Z","timestamp":1775888387322,"version":"3.50.1"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Fundo de Incentivo \u00e0 Pesquisa do Hospital de Cl\u00ednicas de Porto Alegre","award":["18-0246"],"award-info":[{"award-number":["18-0246"]}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["28\/2018"],"award-info":[{"award-number":["28\/2018"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sociedade de Reumatologia do Rio Grande do Sul"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10067-020-05493-7","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T04:33:18Z","timestamp":1604637198000},"page":"2535-2545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Lupus animal models and neuropsychiatric implications"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8013-3510","authenticated-orcid":false,"given":"Tha\u00eds Evelyn","family":"Karnopp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4676-3834","authenticated-orcid":false,"given":"Gustavo Flores","family":"Chapacais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0218-2296","authenticated-orcid":false,"given":"Eduarda Correa","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0720-2097","authenticated-orcid":false,"given":"Odirlei Andr\u00e9","family":"Monticielo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,6]]},"reference":[{"issue":"Suppl","key":"5493_CR1","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1289\/ehp.99107s5723","volume":"107","author":"VM Shaheen","year":"1999","unstructured":"Shaheen VM, Satoh M, Richards HB et al (1999) Immunopathogenesis of environmentally induced lupus in mice. Environ Health Perspect 107(Suppl):723\u2013727. https:\/\/doi.org\/10.1289\/ehp.99107s5723","journal-title":"Environ Health Perspect"},{"key":"5493_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12916-015-0269-8","volume":"13","author":"S Kivity","year":"2015","unstructured":"Kivity S, Agmon-Levin N, Zandman-Goddard G et al (2015) Neuropsychiatric lupus: a mosaic of clinical presentations. BMC Med 13:43. https:\/\/doi.org\/10.1186\/s12916-015-0269-8","journal-title":"BMC Med"},{"key":"5493_CR3","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.autrev.2016.07.009","volume":"15","author":"J Wen","year":"2016","unstructured":"Wen J, Stock AD, Chalmers SA, Putterman C (2016) The role of B cells and autoantibodies in neuropsychiatric lupus. Autoimmun Rev 15:890\u2013895","journal-title":"Autoimmun Rev"},{"key":"5493_CR4","doi-asserted-by":"crossref","unstructured":"Aranow C, Diamond B, Mackay M (2012) Pathogenesis of the nervous system. In: Dubois\u2019 lupus erythematosus and related syndromes: eighth edition. Pp 363\u2013367","DOI":"10.1016\/B978-1-4377-1893-5.00028-5"},{"key":"5493_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1177\/0961203308097448","volume":"18","author":"T Rizos","year":"2009","unstructured":"Rizos T, Siegelin M, H\u00e4hnel S et al (2009) Fulminant onset of cerebral immunocomplex vasculitis as first manifestation of neuropsychiatric systemic lupus erythematosus (NPSLE). Lupus 18:361\u2013363. https:\/\/doi.org\/10.1177\/0961203308097448","journal-title":"Lupus"},{"key":"5493_CR6","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/jcbfm.2014.85","volume":"34","author":"A Vo","year":"2014","unstructured":"Vo A, Volpe BT, Tang CC et al (2014) Regional brain metabolism in a murine systemic lupus erythematosus model. J Cereb Blood Flow Metab 34:1315\u20131320. https:\/\/doi.org\/10.1038\/jcbfm.2014.85","journal-title":"J Cereb Blood Flow Metab"},{"key":"5493_CR7","doi-asserted-by":"publisher","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","volume":"2","author":"A Kaul","year":"2016","unstructured":"Kaul A, Gordon C, Crow MK et al (2016) Systemic lupus erythematosus. Nat Rev Dis Prim 2:16039. https:\/\/doi.org\/10.1038\/nrdp.2016.39","journal-title":"Nat Rev Dis Prim"},{"key":"5493_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/ar3206","volume":"13","author":"W-H Shao","year":"2011","unstructured":"Shao W-H, Cohen PL (2011) Disturbances of apoptotic cell clearance in SLE. Arthritis Res Ther 13:202. https:\/\/doi.org\/10.1186\/ar3206","journal-title":"Arthritis Res Ther"},{"key":"5493_CR9","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1089\/jir.2011.0092","volume":"31","author":"AN Theofilopoulos","year":"2011","unstructured":"Theofilopoulos AN, Kono DH, Beutler B, Baccala R (2011) Intracellular nucleic acid sensors and autoimmunity. J Interf Cytokine Res 31:867\u2013886. https:\/\/doi.org\/10.1089\/jir.2011.0092","journal-title":"J Interf Cytokine Res"},{"key":"5493_CR10","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/0961203314531637","volume":"23","author":"P Nelson","year":"2014","unstructured":"Nelson P, Rylance P, Roden D et al (2014) Viruses as potential pathogenic agents in systemic lupus erythematosus. Lupus 23:596\u2013605. https:\/\/doi.org\/10.1177\/0961203314531637","journal-title":"Lupus"},{"key":"5493_CR11","doi-asserted-by":"publisher","first-page":"102291","DOI":"10.1016\/j.jaut.2019.06.002","volume":"103","author":"SJ Wolf","year":"2019","unstructured":"Wolf SJ, Estadt SN, Theros J et al (2019) Ultraviolet light induces increased T cell activation in lupus-prone mice via type I IFN-dependent inhibition of T regulatory cells. J Autoimmun 103:102291. https:\/\/doi.org\/10.1016\/j.jaut.2019.06.002","journal-title":"J Autoimmun"},{"key":"5493_CR12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.berh.2017.09.005","volume":"31","author":"CG Parks","year":"2017","unstructured":"Parks CG, de Souza Espindola Santos A, Barbhaiya M, Costenbader KH (2017) Understanding the role of environmental factors in the development of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 31:306\u2013320. https:\/\/doi.org\/10.1016\/j.berh.2017.09.005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"5493_CR13","doi-asserted-by":"publisher","first-page":"365083","DOI":"10.1155\/2010\/365083","volume":"2010","author":"DYH Yap","year":"2010","unstructured":"Yap DYH, Lai KN (2010) Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances. J Biomed Biotechnol 2010:365083. https:\/\/doi.org\/10.1155\/2010\/365083","journal-title":"J Biomed Biotechnol"},{"key":"5493_CR14","doi-asserted-by":"publisher","first-page":"e17495","DOI":"10.1371\/journal.pone.0017495","volume":"6","author":"S Sule","year":"2011","unstructured":"Sule S, Rosen A, Petri M et al (2011) Abnormal production of pro- and anti-inflammatory cytokines by lupus monocytes in response to apoptotic cells. PLoS One 6:e17495. https:\/\/doi.org\/10.1371\/journal.pone.0017495","journal-title":"PLoS One"},{"key":"5493_CR15","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1073\/pnas.0337679100","volume":"100","author":"EC Baechler","year":"2003","unstructured":"Baechler EC, Batliwalla FM, Karypis G et al (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100:2610\u20132615. https:\/\/doi.org\/10.1073\/pnas.0337679100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5493_CR16","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1136\/ard.2004.033753","volume":"64","author":"MC Dall\u2019Era","year":"2005","unstructured":"Dall\u2019Era MC, Cardarelli PM, Preston BT et al (2005) Type I interferon correlates with serological and clinical manifestations of SLE. Ann Rheum Dis 64:1692\u20131697. https:\/\/doi.org\/10.1136\/ard.2004.033753","journal-title":"Ann Rheum Dis"},{"key":"5493_CR17","doi-asserted-by":"publisher","unstructured":"Pieterse E, van der Vlag J (2014) Breaking immunological tolerance in systemic lupus erythematosus. Front Immunol 5. https:\/\/doi.org\/10.3389\/fimmu.2014.00164","DOI":"10.3389\/fimmu.2014.00164"},{"key":"5493_CR18","doi-asserted-by":"publisher","unstructured":"Ginzler E, Tayar J (2013) Systemic lupus erythematosus. Am Coll Rheumatol:1\u20136. https:\/\/doi.org\/10.1007\/SpringerReference_61618","DOI":"10.1007\/SpringerReference_61618"},{"key":"5493_CR19","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1136\/ard.2010.130476","volume":"69","author":"GK Bertsias","year":"2010","unstructured":"Bertsias GK, Ioannidis JPA, Aringer M et al (2010) EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 69:2074\u20132082. https:\/\/doi.org\/10.1136\/ard.2010.130476","journal-title":"Ann Rheum Dis"},{"key":"5493_CR20","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","volume":"42","author":"MH Liang","year":"1999","unstructured":"Liang MH, Corzillius M, Bae SC et al (1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42:599\u2013608. https:\/\/doi.org\/10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","journal-title":"Arthritis Rheum"},{"key":"5493_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/CND.0b013e31815202b3","volume":"9","author":"D Lacomis","year":"2007","unstructured":"Lacomis D, \u017divkovi\u0107 SA (2007) Approach to vasculitic neuropathies. J Clin Neuromuscul Dis 9:265\u2013276","journal-title":"J Clin Neuromuscul Dis"},{"key":"5493_CR22","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1007\/s00415-014-7406-8","volume":"261","author":"S Sciascia","year":"2014","unstructured":"Sciascia S, Bertolaccini ML, Roccatello D et al (2014) Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review. J Neurol 261:1706\u20131714. https:\/\/doi.org\/10.1007\/s00415-014-7406-8","journal-title":"J Neurol"},{"key":"5493_CR23","unstructured":"Wallace DJ, Hahn BH (2018) Dubois\u2019 lupus erythematosus and related syndromes"},{"key":"5493_CR24","doi-asserted-by":"crossref","unstructured":"Hanly JG (2014) Diagnosis and management of neuropsychiatric SLE. Nat. Rev. Rheumatol","DOI":"10.1038\/nrrheum.2014.15"},{"key":"5493_CR25","doi-asserted-by":"publisher","unstructured":"Stock AD, Wen J, Putterman C (2013) Neuropsychiatric lupus, the blood brain barrier, and the TWEAK\/Fn14 pathway. Front Immunol 4. https:\/\/doi.org\/10.3389\/fimmu.2013.00484","DOI":"10.3389\/fimmu.2013.00484"},{"key":"5493_CR26","doi-asserted-by":"publisher","unstructured":"Ballok DA, Millward JM, Sakic B (2003) Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining. Brain Res. https:\/\/doi.org\/10.1016\/S0006-8993(02)03980-X","DOI":"10.1016\/S0006-8993(02)03980-X"},{"key":"5493_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00702-005-0375-4","volume":"113","author":"AG De Boer","year":"2006","unstructured":"De Boer AG, Gaillard PJ (2006) Blood-brain barrier dysfunction and recovery. J Neural Transm 113:455\u2013462. https:\/\/doi.org\/10.1007\/s00702-005-0375-4","journal-title":"J Neural Transm"},{"key":"5493_CR28","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/ca.23083","volume":"31","author":"Y Sharif","year":"2018","unstructured":"Sharif Y, Jumah F, Coplan L et al (2018) Blood brain barrier: a review of its anatomy and physiology in health and disease. Clin Anat 31:812\u2013823. https:\/\/doi.org\/10.1002\/ca.23083","journal-title":"Clin Anat"},{"key":"5493_CR29","doi-asserted-by":"crossref","unstructured":"Bonkowski D, Katyshev V, Balabanov RD, et al (2011) The CNS microvascular pericyte: pericyte-astrocyte crosstalk in the regulation of tissue survival. Fluids Barriers CNS 8","DOI":"10.1186\/2045-8118-8-8"},{"key":"5493_CR30","doi-asserted-by":"crossref","unstructured":"Patel JP, Frey BN (2015) Disruption in the blood-brain barrier: the missing link between brain and body inflammation in bipolar disorder? Neural Plast 2015","DOI":"10.1155\/2015\/708306"},{"key":"5493_CR31","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/j.1471-4159.2011.07490.x","volume":"119","author":"A Jacob","year":"2011","unstructured":"Jacob A, Hack B, Chen P et al (2011) C5a\/CD88 signaling alters blood-brain barrier integrity in lupus through nuclear factor-\u03baB. J Neurochem 119:1041\u20131051. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07490.x","journal-title":"J Neurochem"},{"key":"5493_CR32","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.rdc.2017.06.003","volume":"43","author":"K Jafri","year":"2017","unstructured":"Jafri K, Patterson SL, Lanata C (2017) Central nervous system manifestations of systemic lupus erythematosus. Rheum Dis Clin N Am 43:531\u2013545. https:\/\/doi.org\/10.1016\/j.rdc.2017.06.003","journal-title":"Rheum Dis Clin N Am"},{"key":"5493_CR33","doi-asserted-by":"publisher","first-page":"19854","DOI":"10.1073\/pnas.0608397104","volume":"103","author":"C Kowal","year":"2006","unstructured":"Kowal C, DeGiorgio LA, Lee JY et al (2006) Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci 103:19854\u201319859. https:\/\/doi.org\/10.1073\/pnas.0608397104","journal-title":"Proc Natl Acad Sci"},{"key":"5493_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jaut.2018.03.001","volume":"91","author":"S Gelb","year":"2018","unstructured":"Gelb S, Stock AD, Anzi S et al (2018) Mechanisms of neuropsychiatric lupus: the relative roles of the blood-cerebrospinal fluid barrier versus blood-brain barrier. J Autoimmun 91:34\u201344. https:\/\/doi.org\/10.1016\/j.jaut.2018.03.001","journal-title":"J Autoimmun"},{"key":"5493_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jaut.2018.03.001","volume":"91","author":"S Gelb","year":"2018","unstructured":"Gelb S, Stock AD, Anzi S et al (2018) Mechanisms of neuropsychiatric lupus: the relative roles of the blood-CSF versus blood-brain barrier HHS public access. J Autoimmun 91:34\u201344. https:\/\/doi.org\/10.1016\/j.jaut.2018.03.001","journal-title":"J Autoimmun"},{"key":"5493_CR36","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1002\/glia.23154","volume":"65","author":"T Blank","year":"2017","unstructured":"Blank T, Prinz M (2017) Type I interferon pathway in CNS homeostasis and neurological disorders. Glia 65:1397\u20131406. https:\/\/doi.org\/10.1002\/glia.23154","journal-title":"Glia"},{"key":"5493_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10875-015-0147-3","volume":"35","author":"GI Rice","year":"2015","unstructured":"Rice GI, Rodero MP, Crow YJ (2015) Human disease phenotypes associated with mutations in TREX1. J Clin Immunol 35:235\u2013243. https:\/\/doi.org\/10.1007\/s10875-015-0147-3","journal-title":"J Clin Immunol"},{"key":"5493_CR38","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ejmg.2017.09.004","volume":"60","author":"RM Kisla Ekinci","year":"2017","unstructured":"Kisla Ekinci RM, Balci S, Bisgin A et al (2017) A homozygote TREX1 mutation in two siblings with different phenotypes: chilblains and cerebral vasculitis. Eur J Med Genet 60:690\u2013694. https:\/\/doi.org\/10.1016\/j.ejmg.2017.09.004","journal-title":"Eur J Med Genet"},{"key":"5493_CR39","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2174\/157339707781387572","volume":"3","author":"S Appenzeller","year":"2007","unstructured":"Appenzeller S, Costallat LTL (2007) Central nervous system manifestations in systemic lupus erythematosus. Curr Rheumatol Rev 3:205\u2013214. https:\/\/doi.org\/10.2174\/157339707781387572","journal-title":"Curr Rheumatol Rev"},{"key":"5493_CR40","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/ni0901-764","volume":"2","author":"PE Lipsky","year":"2001","unstructured":"Lipsky PE (2001) Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol 2:764\u2013766. https:\/\/doi.org\/10.1038\/ni0901-764","journal-title":"Nat Immunol"},{"key":"5493_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/271694","volume":"2011","author":"D Perry","year":"2011","unstructured":"Perry D, Sang A, Yin Y et al (2011) Murine models of systemic lupus erythematosus. J Biomed Biotechnol 2011:1\u201319. https:\/\/doi.org\/10.1155\/2011\/271694","journal-title":"J Biomed Biotechnol"},{"key":"5493_CR42","doi-asserted-by":"publisher","first-page":"e000199","DOI":"10.1136\/lupus-2016-000199","volume":"5","author":"ML Richard","year":"2018","unstructured":"Richard ML, Gilkeson G (2018) Mouse models of lupus: what they tell us and what they don\u2019t. Lupus Sci Med 5:e000199. https:\/\/doi.org\/10.1136\/lupus-2016-000199","journal-title":"Lupus Sci Med"},{"key":"5493_CR43","first-page":"v9","volume":"269\u2013390","author":"AN Theofilopoulos","year":"1985","unstructured":"Theofilopoulos AN, Dixon FJ (1985) Murine models of systemic lupus erythematosus. Adv Immunol 269\u2013390:v9","journal-title":"Adv Immunol"},{"key":"5493_CR44","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrneurol.2014.148","volume":"10","author":"H Jeltsch-David","year":"2014","unstructured":"Jeltsch-David H, Muller S (2014) Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers. Nat Rev Neurol 10:579\u2013596. https:\/\/doi.org\/10.1038\/nrneurol.2014.148","journal-title":"Nat Rev Neurol"},{"key":"5493_CR45","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1084\/jem.148.5.1198","volume":"148","author":"BS Andrews","year":"1978","unstructured":"Andrews BS, Eisenberg RA, Theofilopoulos AN et al (1978) Spontaneous murine lupus-like syndromes: clinical and immunopathological manifestations in several strains*. J Exp Med 148:1198\u20131215. https:\/\/doi.org\/10.1084\/jem.148.5.1198","journal-title":"J Exp Med"},{"key":"5493_CR46","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s10067-017-3811-6","volume":"36","author":"EC Freitas","year":"2017","unstructured":"Freitas EC, de Oliveira MS, Monticielo OA (2017) Pristane-induced lupus: considerations on this experimental model. Clin Rheumatol 36:2403\u20132414. https:\/\/doi.org\/10.1007\/s10067-017-3811-6","journal-title":"Clin Rheumatol"},{"key":"5493_CR47","doi-asserted-by":"publisher","first-page":"e0217190","DOI":"10.1371\/journal.pone.0217190","volume":"14","author":"J Luciano-Jaramillo","year":"2019","unstructured":"Luciano-Jaramillo J, Sandoval-Garc\u00eda F, V\u00e1zquez-Del Mercado M et al (2019) Downregulation of hippocampal NR2A\/2B subunits related to cognitive impairment in a pristane-induced lupus BALB\/c mice. PLoS One 14:e0217190. https:\/\/doi.org\/10.1371\/journal.pone.0217190","journal-title":"PLoS One"},{"key":"5493_CR48","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1002\/art.23023","volume":"56","author":"DC Nacionales","year":"2007","unstructured":"Nacionales DC, Kelly-Scumpia KM, Lee PY et al (2007) Deficiency of the type I interferon receptor protects mice from experimental lupus. Arthritis Rheum 56:3770\u20133783. https:\/\/doi.org\/10.1002\/art.23023","journal-title":"Arthritis Rheum"},{"key":"5493_CR49","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/08916934.2019.1613383","volume":"52","author":"E Correa Freitas","year":"2019","unstructured":"Correa Freitas E, Evelyn Karnopp T, de Souza Silva JM et al (2019) Vitamin D supplementation ameliorates arthritis but does not alleviates renal injury in pristane-induced lupus model. Autoimmunity 52:69\u201377. https:\/\/doi.org\/10.1080\/08916934.2019.1613383","journal-title":"Autoimmunity"},{"key":"5493_CR50","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0021-9975(08)80122-3","volume":"102","author":"AB Kier","year":"1990","unstructured":"Kier AB (1990) Clinical neurology and brain histopathology in NZB\/NZW F1 lupus mice. J Comp Pathol 102:165\u2013177. https:\/\/doi.org\/10.1016\/S0021-9975(08)80122-3","journal-title":"J Comp Pathol"},{"key":"5493_CR51","doi-asserted-by":"publisher","unstructured":"Gao HX, Campbell SR, Cui MH et al (2009) Depression is an early disease manifestation in lupus-prone MRL\/lpr mice. J Neuroimmunol. https:\/\/doi.org\/10.1016\/j.jneuroim.2008.11.009","DOI":"10.1016\/j.jneuroim.2008.11.009"},{"key":"5493_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/207504","volume":"2011","author":"M Gulinello","year":"2011","unstructured":"Gulinello M, Putterman C (2011) The MRL\/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus. J Biomed Biotechnol 2011:1\u201315. https:\/\/doi.org\/10.1155\/2011\/207504","journal-title":"J Biomed Biotechnol"},{"key":"5493_CR53","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/0031-9384(94)90309-3","volume":"56","author":"B \u0160aki\u0107","year":"1994","unstructured":"\u0160aki\u0107 B, Szechtman H, Talangbayan H et al (1994) Disturbed emotionality in autoimmune MRL-lpr mice. Physiol Behav 56:609\u2013617. https:\/\/doi.org\/10.1016\/0031-9384(94)90309-3","journal-title":"Physiol Behav"},{"key":"5493_CR54","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.2147\/DDDT.S114501","volume":"10","author":"Y-YY He","year":"2016","unstructured":"He Y-YY, Yan YY, Zhang H-FF et al (2016) Methyl salicylate 2-O-\u03b2-D-lactoside alleviates the pathological progression of pristane-induced systemic lupus erythematosus-like disease in mice via suppression of inflammatory response and signal transduction. Drug Des Devel Ther Volume 10:3183\u20133196. https:\/\/doi.org\/10.2147\/DDDT.S114501","journal-title":"Drug Des Devel Ther Volume"},{"key":"5493_CR55","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1046\/j.1365-3083.2000.00789.x","volume":"52","author":"WM Wu","year":"2000","unstructured":"Wu WM, Lin BF, Su YC et al (2000) Tamoxifen decreases renal inflammation and alleviates disease severity autoimmune NZB\/W F1 mice. Scand J Immunol 52:393\u2013400. https:\/\/doi.org\/10.1046\/j.1365-3083.2000.00789.x","journal-title":"Scand J Immunol"},{"key":"5493_CR56","doi-asserted-by":"publisher","unstructured":"Zhuang H, Szeto C, Han S et al (2015) Animal models of interferon signature positive lupus. Front Immunol 6. https:\/\/doi.org\/10.3389\/fimmu.2015.00291","DOI":"10.3389\/fimmu.2015.00291"},{"key":"5493_CR57","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/intimm\/3.3.273","volume":"3","author":"B Tang","year":"1991","unstructured":"Tang B, Matsuda T, Akira S et al (1991) Age-associated increase in interleukin 6 in MRL\/lpr mice. Int Immunol 3:273\u2013278","journal-title":"Int Immunol"},{"key":"5493_CR58","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1365-3083.1995.tb03548.x","volume":"41","author":"C-Y Tsai","year":"1995","unstructured":"Tsai C-Y, Wu T-H, Huang S-F et al (1995) Abnormal splenic and thymic IL-4 and TNF-\u03b1 expression in MRL-lpr\/lpr mice. Scand J Immunol 41:157\u2013163. https:\/\/doi.org\/10.1111\/j.1365-3083.1995.tb03548.x","journal-title":"Scand J Immunol"},{"key":"5493_CR59","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s10753-013-9802-0","volume":"37","author":"P Li","year":"2014","unstructured":"Li P, Lin W, Zheng X (2014) IL-33 neutralization suppresses lupus disease in lupus-prone mice. Inflammation 37:824\u2013832. https:\/\/doi.org\/10.1007\/s10753-013-9802-0","journal-title":"Inflammation"},{"key":"5493_CR60","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1002\/art.1780221105","volume":"22","author":"ED Murphy","year":"1979","unstructured":"Murphy ED, Roths JB (1979) A y chromosome associated factor in strain bxsb producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum 22:1188\u20131194. https:\/\/doi.org\/10.1002\/art.1780221105","journal-title":"Arthritis Rheum"},{"key":"5493_CR61","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1084\/jem.180.6.2341","volume":"180","author":"M Satoh","year":"1994","unstructured":"Satoh M (1994) Induction of lupus-associated autoantibodies in BALB\/c mice by intraperitoneal injection of pristane. J Exp Med 180:2341\u20132346. https:\/\/doi.org\/10.1084\/jem.180.6.2341","journal-title":"J Exp Med"},{"key":"5493_CR62","doi-asserted-by":"publisher","first-page":"10934","DOI":"10.1073\/pnas.92.24.10934","volume":"92","author":"M Satoh","year":"1995","unstructured":"Satoh M, Kumar A, Kanwar YS, Reeves WH (1995) Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB\/c mice treated with pristane. Proc Natl Acad Sci U S A 92:10934\u201310938. https:\/\/doi.org\/10.1073\/pnas.92.24.10934","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5493_CR63","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.4049\/jimmunol.157.7.3200","volume":"157","author":"M Satoh","year":"1996","unstructured":"Satoh M, Hamilton KJ, Ajmani AK et al (1996) Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane. J Immunol 157:3200\u20133206","journal-title":"J Immunol"},{"key":"5493_CR64","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1046\/j.1365-2249.2000.01276.x","volume":"121","author":"M Satoh","year":"2000","unstructured":"Satoh M, Richards HB, Shaheen VM et al (2000) Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane. Clin Exp Immunol 121:399\u2013405. https:\/\/doi.org\/10.1046\/j.1365-2249.2000.01276.x","journal-title":"Clin Exp Immunol"},{"key":"5493_CR65","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1084\/jem.188.5.985","volume":"188","author":"HB Richards","year":"2002","unstructured":"Richards HB (2002) Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus. J Exp Med 188:985\u2013990. https:\/\/doi.org\/10.1084\/jem.188.5.985","journal-title":"J Exp Med"},{"key":"5493_CR66","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.it.2009.06.003","volume":"30","author":"WH Reeves","year":"2009","unstructured":"Reeves WH, Lee PY, Weinstein JS et al (2009) Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol 30:455\u2013464. https:\/\/doi.org\/10.1016\/j.it.2009.06.003","journal-title":"Trends Immunol"},{"key":"5493_CR67","doi-asserted-by":"publisher","first-page":"17","DOI":"10.21315\/mjms2018.25.3.3","volume":"25","author":"H Kalim","year":"2018","unstructured":"Kalim H, Pratama MZ, Nugraha AS et al (2018) Regulatory T cells compensation failure cause the dysregulation of immune response in pristane induced lupus mice model. Malays J Med Sci 25:17\u201326. https:\/\/doi.org\/10.21315\/mjms2018.25.3.3","journal-title":"Malays J Med Sci"},{"key":"5493_CR68","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41584-018-0156-8","volume":"15","author":"N Schwartz","year":"2019","unstructured":"Schwartz N, Stock AD, Putterman C (2019) Neuropsychiatric lupus: new mechanistic insights and future treatment directions. Nat Rev Rheumatol 15:137\u2013152","journal-title":"Nat Rev Rheumatol"},{"key":"5493_CR69","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1177\/0961203319828499","volume":"28","author":"A Bortoluzzi","year":"2019","unstructured":"Bortoluzzi A, Piga M, Silvagni E et al (2019) Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome. Lupus 28:465\u2013474. https:\/\/doi.org\/10.1177\/0961203319828499","journal-title":"Lupus"},{"key":"5493_CR70","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.3390\/ijms19113588","volume":"19","author":"M Bendorius","year":"2018","unstructured":"Bendorius M, Po C, Muller S, Jeltsch-David H (2018) From systemic inflammation to neuroinflammation: the case of neurolupus. Int J Mol Sci 19:3588. https:\/\/doi.org\/10.3390\/ijms19113588","journal-title":"Int J Mol Sci"},{"key":"5493_CR71","doi-asserted-by":"publisher","unstructured":"Helyer BJ, Howie JB (1963) Renal disease associated with positive lupus erythematosus tests in a crossbred strain of mice. Nature. https:\/\/doi.org\/10.1038\/197197a0","DOI":"10.1038\/197197a0"},{"key":"5493_CR72","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.4049\/jimmunol.154.5.2441","volume":"54","author":"CG Drake","year":"1995","unstructured":"Drake CG, Rozzo SJ, Hirschfeld HF et al (1995) Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner. J Immunol 54:2441\u20132447","journal-title":"J Immunol"},{"key":"5493_CR73","doi-asserted-by":"crossref","unstructured":"Bracci-Laudiero L, Aloe L, Lundeberg T, et al (1999) Altered levels of neuropeptides characterize the brain of lupus prone mice. Neurosci Lett","DOI":"10.1016\/S0304-3940(99)00737-5"},{"key":"5493_CR74","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.brainresrev.2006.12.003","volume":"54","author":"DA Ballok","year":"2007","unstructured":"Ballok DA (2007) Neuroimmunopathology in a murine model of neuropsychiatric lupus. Brain Res Rev 54:67\u201379. https:\/\/doi.org\/10.1016\/j.brainresrev.2006.12.003","journal-title":"Brain Res Rev"},{"key":"5493_CR75","doi-asserted-by":"publisher","unstructured":"Murphy ED, Roths JB (1979) A y chromosome associated factor in strain bxsb producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum https:\/\/doi.org\/10.1002\/art.1780221105","DOI":"10.1002\/art.1780221105"},{"key":"5493_CR76","doi-asserted-by":"publisher","first-page":"15150","DOI":"10.3390\/ijms160715150","volume":"16","author":"Y Li","year":"2015","unstructured":"Li Y, Eskelund AR, Zhou H et al (2015) Behavioral deficits are accompanied by immunological and neurochemical changes in a mouse model for neuropsychiatric lupus (NP-SLE). Int J Mol Sci 16:15150\u201315171. https:\/\/doi.org\/10.3390\/ijms160715150","journal-title":"Int J Mol Sci"},{"key":"5493_CR77","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/hipo.10205","volume":"14","author":"DA Ballok","year":"2004","unstructured":"Ballok DA, Woulfe J, Sur M et al (2004) Hippocampal damage in mouse and human forms of systemic autoimmune disease. Hippocampus 14:649\u2013661","journal-title":"Hippocampus"},{"key":"5493_CR78","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s40674-014-0009-9","volume":"1","author":"GS Gilkeson","year":"2015","unstructured":"Gilkeson GS (2015) Complement-targeted therapies in lupus. Curr Treat Options Rheumatol 1:10\u201318. https:\/\/doi.org\/10.1007\/s40674-014-0009-9","journal-title":"Curr Treat Options Rheumatol"},{"key":"5493_CR79","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bbadis.2003.09.005","volume":"1639","author":"JJ Alexander","year":"2003","unstructured":"Alexander JJ, Bao L, Jacob A et al (2003) Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis. Biochim Biophys Acta Mol basis Dis 1639:169\u2013176. https:\/\/doi.org\/10.1016\/j.bbadis.2003.09.005","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"5493_CR80","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jneuroim.2006.06.023","volume":"179","author":"X Ma","year":"2006","unstructured":"Ma X, Foster J, Sakic B (2006) Distribution and prevalence of leukocyte phenotypes in brains of lupus-prone mice. J Neuroimmunol 179:26\u201336. https:\/\/doi.org\/10.1016\/j.jneuroim.2006.06.023","journal-title":"J Neuroimmunol"},{"key":"5493_CR81","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.3389\/fimmu.2018.02189","volume":"9","author":"EV Mike","year":"2018","unstructured":"Mike EV, Makinde HM, Der E et al (2018) Neuropsychiatric systemic lupus erythematosus is dependent on sphingosine-1-phosphate signaling. Front Immunol 9:2189. https:\/\/doi.org\/10.3389\/fimmu.2018.02189","journal-title":"Front Immunol"},{"key":"5493_CR82","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1136\/ard.59.4.243","volume":"59","author":"GS Dean","year":"2000","unstructured":"Dean GS (2000) Cytokines and systemic lupus erythematosus. Ann Rheum Dis 59:243\u2013251. https:\/\/doi.org\/10.1136\/ard.59.4.243","journal-title":"Ann Rheum Dis"},{"key":"5493_CR83","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.yebeh.2014.01.017","volume":"38","author":"GM Arisi","year":"2014","unstructured":"Arisi GM (2014) Nervous and immune systems signals and connections: cytokines in hippocampus physiology and pathology. Epilepsy Behav 38:43\u201347","journal-title":"Epilepsy Behav"},{"key":"5493_CR84","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/YCO.0b013e328315a561","volume":"22","author":"TG Dinan","year":"2009","unstructured":"Dinan TG, Dinan T (2009) Inflammatory markers in depression. Curr Opin Psychiatry 22:32\u201336","journal-title":"Curr Opin Psychiatry"},{"key":"5493_CR85","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.mehy.2003.10.009","volume":"62","author":"M Tomita","year":"2004","unstructured":"Tomita M, Khan RL, Blehm BH, Santoro TJ (2004) The potential pathogenetic link between peripheral immune activation and the central innate immune response in neuropsychiatric systemic lupus erythematosus. Med Hypotheses 62:325\u2013335. https:\/\/doi.org\/10.1016\/j.mehy.2003.10.009","journal-title":"Med Hypotheses"},{"key":"5493_CR86","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/eji.201343714","volume":"44","author":"J-HH Han","year":"2014","unstructured":"Han J-HH, Umiker BR, Kazimirova AA et al (2014) Expression of an anti-RNA autoantibody in a mouse model of SLE increases neutrophil and monocyte numbers as well as IFN-I expression. Eur J Immunol 44:215\u2013226. https:\/\/doi.org\/10.1002\/eji.201343714","journal-title":"Eur J Immunol"},{"key":"5493_CR87","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.bbi.2018.03.009","volume":"70","author":"D Shi","year":"2018","unstructured":"Shi D, Tian T, Yao S et al (2018) FTY720 attenuates behavioral deficits in a murine model of systemic lupus erythematosus. Brain Behav Immun 70:293\u2013304. https:\/\/doi.org\/10.1016\/j.bbi.2018.03.009","journal-title":"Brain Behav Immun"},{"key":"5493_CR88","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaut.2018.08.005","volume":"96","author":"EV Mike","year":"2019","unstructured":"Mike EV, Makinde HM, Gulinello M et al (2019) Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus. J Autoimmun 96:59\u201373. https:\/\/doi.org\/10.1016\/j.jaut.2018.08.005","journal-title":"J Autoimmun"},{"key":"5493_CR89","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.4049\/jimmunol.1400122","volume":"192","author":"CM Cuda","year":"2014","unstructured":"Cuda CM, Misharin AV, Gierut AK et al (2014) Caspase-8 acts as a molecular rheostat to limit RIPK1- and MyD88-mediated dendritic cell activation. J Immunol 192:5548\u20135560. https:\/\/doi.org\/10.4049\/jimmunol.1400122","journal-title":"J Immunol"},{"key":"5493_CR90","doi-asserted-by":"publisher","unstructured":"Makinde HM, Winter DR, Procissi D et al (2020) A novel microglia-specific transcriptional signature correlates with behavioral deficits in neuropsychiatric lupus. Front Immunol 11. https:\/\/doi.org\/10.3389\/fimmu.2020.00230","DOI":"10.3389\/fimmu.2020.00230"},{"key":"5493_CR91","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2353\/ajpath.2006.050125","volume":"168","author":"DC Nacionales","year":"2006","unstructured":"Nacionales DC, Kelly KM, Lee PY et al (2006) Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane). Am J Pathol 168:1227\u20131240. https:\/\/doi.org\/10.2353\/ajpath.2006.050125","journal-title":"Am J Pathol"},{"key":"5493_CR92","doi-asserted-by":"publisher","first-page":"8312","DOI":"10.4049\/jimmunol.175.12.8312","volume":"175","author":"JJ Alexander","year":"2005","unstructured":"Alexander JJ, Jacob A, Bao L et al (2005) Complement-dependent apoptosis and inflammatory gene changes in murine lupus cerebritis. J Immunol 175:8312\u20138319. https:\/\/doi.org\/10.4049\/jimmunol.175.12.8312","journal-title":"J Immunol"},{"key":"5493_CR93","doi-asserted-by":"publisher","first-page":"5101","DOI":"10.4049\/jimmunol.180.7.5101","volume":"180","author":"PY Lee","year":"2014","unstructured":"Lee PY, Weinstein JS, Nacionales DC et al (2014) A novel type I IFN-producing cell subset in murine lupus. J Immunol 180:5101\u20135108. https:\/\/doi.org\/10.4049\/jimmunol.180.7.5101","journal-title":"J Immunol"},{"key":"5493_CR94","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0304-3940(01)01679-2","volume":"302","author":"M Tomita","year":"2001","unstructured":"Tomita M, Holman BJ, Santoro TJ (2001) Aberrant cytokine gene expression in the hippocampus in murine systemic lupus erythematosus. Neurosci Lett 302:129\u2013132. https:\/\/doi.org\/10.1016\/S0304-3940(01)01679-2","journal-title":"Neurosci Lett"},{"key":"5493_CR95","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/jnr.1050","volume":"64","author":"M Tomita","year":"2001","unstructured":"Tomita M, Holman BJ, Williams LS et al (2001) Cerebellar dysfunction is associated with overexpression of proinflammatory cytokine genes in lupus. J Neurosci Res 64:26\u201333. https:\/\/doi.org\/10.1002\/jnr.1050","journal-title":"J Neurosci Res"},{"key":"5493_CR96","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.autrev.2014.08.015","volume":"13","author":"H Jeltsch-David","year":"2014","unstructured":"Jeltsch-David H, Muller S (2014) Neuropsychiatric systemic lupus erythematosus and cognitive dysfunction: the MRL-lpr mouse strain as a model. Autoimmun Rev 13:963\u2013973. https:\/\/doi.org\/10.1016\/j.autrev.2014.08.015","journal-title":"Autoimmun Rev"},{"key":"5493_CR97","first-page":"207","volume-title":"Genetic control of autoimmune disease","author":"E Murphy","year":"1978","unstructured":"Murphy E, Roths J (1978) Autoimmunity and lymphoproliferation. Induction by mutant gene lpr, and acceleration by a male-associated factor in strain BXSB mice. In: Rose N, Bigazzi P, Warner N (eds) Genetic control of autoimmune disease. Elsevier, New York, pp 207\u2013221"},{"key":"5493_CR98","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1346-8138.1982.tb01091.x","volume":"9","author":"F Furukawa","year":"1982","unstructured":"Furukawa F, Hamashima Y (1982) Lupus band test in New Zealand mice and MRL mice. J Dermatol 9:467\u2013471. https:\/\/doi.org\/10.1111\/j.1346-8138.1982.tb01091.x","journal-title":"J Dermatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05493-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05493-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05493-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T16:27:51Z","timestamp":1697041671000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05493-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,6]]},"references-count":98,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["5493"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05493-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,6]]},"assertion":[{"value":"2 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}